| References |
|
|
Andrews B and
Measday V
(1998)
The cyclin family of budding yeast: abundant use of a good idea.
Trends in Genetics
14:
66–72.
|
|
|
Berardi P,
Meyyappan M and
Riabowol KT
(2003)
A novel transcriptional inhibitory element differentially regulates the cyclin D1 gene in senescent cells.
Journal of Biological Chemistry
278:
7510–7519.
|
|
|
Brandeis M,
Rosewell I,
Carrington M et al.
(1998)
Cyclin B2‐null mice develop normally and are fertile whereas cyclin B1‐null mice die in utero.
Proceedings of the National Academy of Sciences of the USA
95:
4344–4349.
|
|
|
Ciemerych MA,
Kenney AM,
Sicinska E et al.
(2002)
Development of mice expressing a single D‐type cyclin.
Genes & Development
16:
3277–3289.
|
|
|
D'Angiolella V,
Donato V,
Vijayakumar S et al.
(2010)
SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradation.
Nature
466:
138–142.
|
|
|
Diehl JA,
Yang W,
Rimerman RA,
Xiao H and
Emili A
(2003)
Hsc70 regulates accumulation of cyclin D1 and cyclin D1‐dependent protein kinase.
Molecular and Cellular Biology
23:
1764–1774.
|
|
|
Dulic V,
Drullinger LF,
Lees E,
Reed SI and
Stein GH
(1993)
Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E‐Cdk2 and cyclin D1‐Cdk2 complexes.
Proceedings of the National Academy of Sciences of the USA
90:
11034–11038.
|
|
|
Evans T,
Rosenthal ET,
Youngblom J,
Distel D and
Hunt T
(1983)
Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division.
Cell
33:
389–396.
|
|
|
Geng Y,
Yu Q,
Sicinska E et al.
(2003)
Cyclin E ablation in the mouse.
Cell
114:
431–443.
|
|
|
Goda T,
Ishii T,
Nakajo N,
Sagata N and
Kobayashi H
(2003)
The RRASK motif in Xenopus cyclin B2 is required for the substrate recognition of Cdc25C by the cyclin B‐Cdc2 complex.
Journal of Biological Chemistry
278:
19032–19037.
|
|
|
Jeffrey PD,
Russo AA,
Polyak K et al.
(1995)
Mechanism of CDK activation revealed by the structure of a cyclinA‐CDK2 complex.
Nature
376:
313–320.
|
|
|
Kelly BL,
Wolfe KG and
Roberts JM
(1998)
Identification of a substrate‐targeting domain in cyclin E necessary for phosphorylation of the retinoblastoma protein.
Proceedings of the National Academy of Sciences of the USA
95:
2535–2540.
|
|
|
Kikuchi I,
Nakayama Y,
Morinaga T,
Fukumoto Y and
Yamaguchi N
(2010)
A decrease in cyclin B1 levels leads to polyploidization in DNA damage‐induced senescence.
Cell Biol International
34:
645–653.
|
|
|
Koivomagi M,
Valk E,
Venta R et al.
(2011)
Dynamics of Cdk1 substrate specificity during the cell cycle.
Molecular Cell
42:
610–623.
|
|
|
Masui Y and
Markert CL
(1971)
Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes.
Journal of Experimental Zoology
177:
129–145.
|
|
|
Miller ME and
Cross FR
(2001)
Cyclin specificity: how many wheels do you need on a unicycle?
Journal of Cell Science
114:
1811–1820.
|
|
|
Morgan DO
(1997)
Cyclin‐dependent kinases: engines, clocks, and microprocessors.
Annual Review of Cell and Developmental Biology
13:
261–291.
|
|
|
Murray AW and
Kirschner MW
(1989)
Cyclin synthesis drives the early embryonic cell cycle.
Nature
339:
275–280.
|
|
|
Nurse P
(1990)
Universal control mechanism regulating onset of M‐phase.
Nature
344:
503–508.
|
|
|
Ren S and
Rollins BJ
(2004)
Cyclin C/cdk3 promotes Rb‐dependent G0 exit.
Cell
117:
239–251.
|
|
|
Shan J,
Zhao W and
Gu W
(2009)
Suppression of cancer cell growth by promoting cyclin D1 degradation.
Molecular Cell
36:
469–476.
|
|
|
Susa M,
Choy E,
Liu X et al.
(2010)
Cyclin G‐associated kinase is necessary for osteosarcoma cell proliferation and receptor trafficking.
Molecular Cancer Therapeutics
9:
3342–3350.
|
|
|
Swenson KI,
Farrell KM and
Ruderman JV
(1986)
The clam embryo protein cyclin A induces entry into M phase and the resumption of meiosis in Xenopus oocytes.
Cell
47:
861–870.
|
|
|
Tanenbaum ME,
Vallenius T,
Geers EF et al.
(2010)
Cyclin G‐associated kinase promotes microtubule outgrowth from chromosomes during spindle assembly.
Chromosoma
119:
415–424.
|
|
|
Townsley FM and
Ruderman JV
(1998)
Proteolytic ratchets that control progression through mitosis.
Trends in Cell Biology
8:
238–244.
|
|
|
Verges E,
Colomina N,
Gari E,
Gallego C and
Aldea M
(2007)
Cyclin Cln3 is retained at the ER and released by the J chaperone Ydj1 in late G1 to trigger cell cycle entry.
Molecular Cell
26:
649–662.
|
|
|
Wohlschlegel JA,
Dwyer BT,
Takeda DY and
Dutta A
(2001)
Mutational analysis of the Cy motif from p21 reveals sequence degeneracy and specificity for different cyclin‐dependent kinases.
Molecular and Cellular Biology
21:
4868–4874.
|
|
|
Yu DS and
Cortez D
(2011)
A role for CDK9‐cyclin K in maintaining genome integrity.
Cell Cycle
10:
28–32.
|
| Further Reading |
|
|
Barraclough J,
Stone A and
Sutherland RL
(2011)
Cyclin D as a therapeutic target in cancer.
Nature Reviews Cancer
11:
558–572.
|
|
|
Bloom J and
Cross FR
(2007)
Multiple levels of cyclin specificity in cell‐cycle control.
Nature Reviews Molecular Cell Biology
8:
149–160.
|
|
|
Brown NR,
Noble ME,
Endicott JA and
Johnson LN
(1999a)
The structural basis for specificity of substrate and recruitment peptides for cyclin‐dependent kinases.
Nature cell biology
1:
438.
|
|
|
Brown NR,
Noble ME,
Lawrie AM et al.
(1999b)
Effects of phosphorylation of threonine 160 on cyclin‐dependent kinase 2 structure and activity.
Journal of Biological Chemistry
274:
8746.
|
|
|
Hochegger H,
Takeda S and
Hunt T
(2008)
Cyclin‐dependent kinases and cell‐cycle transitions: does one fit all?
Nature Reviews Molecular Cell Biology
9:
910–916.
|
|
|
Jackson PK
(2008)
The hunt for cyclin.
Cell
134:
199–202.
|
|
|
Malumbres M and
Barbacid M
(2009)
Cell cycle, CDKs and cancer: a changing paradigm.
Nature Reviews Cancer
9:
153–166.
|
|
|
Martin S
(2011)
Deconstructing the cell cycle.
Nature Reviews Molecular Cell Biology
12:
689.
|
|
|
Russo AA,
Jeffrey PD,
Patten AK,
Massague J and
Pavletich NP
(1996)
Crystal structure of the p27kip1 cyclin‐dependent‐kinase inhibitor bound to the cyclin a‐cdk2 complex.
Nature
382:
325.
|
|
|
Russo AA,
Tong L,
Lee JO,
Jeffrey PD and
Pavletich NP
(1998)
Structural basis for inhibition of the cyclin‐dependent kinase cdk6 by the tumour suppressor p16ink4a.
Nature
395:
237.
|